US equities
|
MU
$975.95
▲+5.08%
SNDK
$1,372.27
▲+5.17%
SPCX
$144.75
▼-2.57%
META
$620.29
▲+0.02%
TSLA
$404.79
▼-0.66%
SKHY
$160.01
▲+10.08%
NVDA
$219.11
▲+0.54%
GOOGL
$324.49
▲+1.22%
MU
$975.95
▲+5.08%
SNDK
$1,372.27
▲+5.17%
SPCX
$144.75
▼-2.57%
META
$620.29
▲+0.02%
TSLA
$404.79
▼-0.66%
SKHY
$160.01
▲+10.08%
NVDA
$219.11
▲+0.54%
GOOGL
$324.49
▲+1.22%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Ipsen and Exicure, Inc.
Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
August 02, 2021
From
Ipsen and Exicure, Inc.
Via
Business Wire
Tickers
OTC
XCUR
